PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-47.69%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
0.48%
Positive gross profit growth while XRF.AX is negative. John Neff would see a clear operational edge over the competitor.
-48.14%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-48.14%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-64.13%
Negative net income growth while XRF.AX stands at 13.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-62.96%
Negative EPS growth while XRF.AX is at 12.54%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-62.96%
Negative diluted EPS growth while XRF.AX is at 12.54%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.58%
Share reduction while XRF.AX is at 1.21%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.64%
Diluted share count expanding well above XRF.AX's 1.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-163.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-180.97%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
482.38%
10Y revenue/share CAGR above 1.5x XRF.AX's 151.40%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
546.35%
5Y revenue/share CAGR above 1.5x XRF.AX's 74.52%. David Dodd would look for consistent product or market expansions fueling outperformance.
314.68%
3Y revenue/share CAGR above 1.5x XRF.AX's 49.22%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-2943.31%
Negative 10Y OCF/share CAGR while XRF.AX stands at 132.15%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-6929.20%
Negative 5Y OCF/share CAGR while XRF.AX is at 1139.05%. Joel Greenblatt would question the firm’s operational model or cost structure.
-250.99%
Negative 3Y OCF/share CAGR while XRF.AX stands at 144.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
2072.00%
Net income/share CAGR above 1.5x XRF.AX's 198.79% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1593.94%
5Y net income/share CAGR above 1.5x XRF.AX's 195.12%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
469.94%
3Y net income/share CAGR above 1.5x XRF.AX's 72.97%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
86332.39%
10Y equity/share CAGR above 1.5x XRF.AX's 74.40%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
238.84%
5Y equity/share CAGR above 1.5x XRF.AX's 52.04%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
74.60%
3Y equity/share CAGR above 1.5x XRF.AX's 30.57%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
96.60%
Inventory growth well above XRF.AX's 4.59%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
19.14%
Positive asset growth while XRF.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
20.81%
Positive BV/share change while XRF.AX is negative. John Neff sees a clear edge over a competitor losing equity.
111.67%
Debt growth far above XRF.AX's 35.08%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
94.56%
We expand SG&A while XRF.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.